LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 267 individual holdings. The top holdings are Gilead Sciences stock at 7.81%, Vertex Pharmaceuticals at 7.71%, Amgen at 7.67%, Regeneron Pharmaceuticals at 6.37%, and Alnylam Pharmaceuticals at 3.57%.

Total Holdings

267

Top 10 Percentage

43.34%

Asset Class

Equity

ETF Category

Health Care

Assets

647.52M

PE Ratio

21.65

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.81%	517,400
2	VRTX	Vertex Pharmaceuticals Incorporated	7.71%	155,111
3	AMGN	Amgen Inc.	7.67%	198,548
4	REGN	Regeneron Pharmaceuticals, Inc.	6.37%	77,817
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.57%	99,326
6	INSM	Insmed Incorporated	2.61%	161,427
7	BIIB	Biogen Inc.	2.27%	109,914
8	UTHR	United Therapeutics Corporation	1.94%	32,821
9	MRNA	Moderna, Inc.	1.73%	295,774
10	RPRX	Royalty Pharma plc	1.65%	321,547
11	ARGX	argenx SE	1.62%	21,234
12	ROIV	Roivant Sciences Ltd.	1.61%	537,138
13	ILMN	Illumina, Inc.	1.58%	114,405
14	RVMD	Revolution Medicines, Inc.	1.53%	148,416
15	INCY	Incyte Corporation	1.50%	149,040
16	VTRS	Viatris Inc.	1.27%	862,289
17	BBIO	BridgeBio Pharma, Inc.	1.14%	145,711
18	SMMT	Summit Therapeutics Inc.	1.14%	580,687
19	ASND	Ascendis Pharma A/S	1.11%	46,066
20	MEDP	Medpace Holdings, Inc.	1.08%	21,241
21	NBIX	Neurocrine Biosciences, Inc.	1.08%	75,099
22	IONS	Ionis Pharmaceuticals, Inc.	0.98%	123,602
23	JAZZ	Jazz Pharmaceuticals plc	0.96%	46,305
24	GH	Guardant Health, Inc.	0.93%	98,145
25	SNY	Sanofi	0.92%	183,140

Showing 25 of 267 holdings

Subscribe to see the full list

Activate Now

As of Mar 25, 2026